LLY

753.95

+2.28%↑

JNJ

151.07

+1.12%↑

UNH

291.93

+7.04%↑

ABBV

183.3

+0.85%↑

NVO

64.06

-2.9%↓

LLY

753.95

+2.28%↑

JNJ

151.07

+1.12%↑

UNH

291.93

+7.04%↑

ABBV

183.3

+0.85%↑

NVO

64.06

-2.9%↓

LLY

753.95

+2.28%↑

JNJ

151.07

+1.12%↑

UNH

291.93

+7.04%↑

ABBV

183.3

+0.85%↑

NVO

64.06

-2.9%↓

LLY

753.95

+2.28%↑

JNJ

151.07

+1.12%↑

UNH

291.93

+7.04%↑

ABBV

183.3

+0.85%↑

NVO

64.06

-2.9%↓

LLY

753.95

+2.28%↑

JNJ

151.07

+1.12%↑

UNH

291.93

+7.04%↑

ABBV

183.3

+0.85%↑

NVO

64.06

-2.9%↓

Search

Elevance Health Inc

Atvērts

SektorsVeselības aprūpe

403.07 3.52

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

389.37

Max

403

Galvenie mērījumi

By Trading Economics

Ienākumi

1.8B

2.2B

Pārdošana

3.4B

49B

P/E

Sektora vidējais

16.207

56.602

EPS

11.97

Dividenžu ienesīgums

1.64

Peļņas marža

4.467

Darbinieki

104,200

EBITDA

1.8B

3.1B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+32.96% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.64%

2.45%

Nākamie ieņēmumi

2025. g. 16. jūl.

Nākamais dividenžu datums

2025. g. 25. jūn.

Nākamais Ex dividenžu datums

2025. g. 10. jūn.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

2.9B

94B

Iepriekšējā atvēršanas cena

399.55

Iepriekšējā slēgšanas cena

403.07

Ziņu noskaņojums

By Acuity

43%

57%

150 / 382 Rangs Healthcare

Elevance Health Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 13. maijs 17:18 UTC

Galvenie tirgus virzītāji

Health Insurers See Shares Drop After UnitedHealth Suspends Guidance

2025. g. 1. maijs 20:13 UTC

Galvenie tirgus virzītāji

Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint

2025. g. 22. apr. 10:33 UTC

Peļņas

Elevance Health 1Q Revenue Climbs with More Members, Higher Yields

2025. g. 17. apr. 15:40 UTC

Peļņas

Elevance Health Says 1Q Costs In Line with Expectations

2025. g. 23. janv. 11:52 UTC

Peļņas

Elevance Health Expects Higher Revenue, Profit in 2025

2025. g. 14. maijs 09:30 UTC

Top Ziņas

Why UnitedHealth's Blowup May Be More Isolated Than Investors Think -- Heard on the Street -- WSJ

2025. g. 1. maijs 23:14 UTC

Top Ziņas

Justice Department Sues Big Medicare Insurers Alleging Kickbacks -- 2nd Update

2025. g. 1. maijs 21:20 UTC

Top Ziņas

Justice Department Sues Big Medicare Insurers Alleging Kickbacks -- Update

2025. g. 22. apr. 10:02 UTC

Peļņas

Elevance Health Sees 2025 Adj EPS $34.15-Adj EPS $34.85 >ELV

2025. g. 22. apr. 10:01 UTC

Peļņas

Elevance Health Sees 2025 EPS $28.30-EPS $29.00 >ELV

2025. g. 22. apr. 10:00 UTC

Peļņas

Elevance Health 1Q Benefit Expense Ratio 86.4% >ELV

2025. g. 22. apr. 10:00 UTC

Peļņas

Elevance Health 1Q Rev $48.89B >ELV

2025. g. 22. apr. 10:00 UTC

Peļņas

Elevance Health 1Q Net $2.18B >ELV

2025. g. 22. apr. 10:00 UTC

Peļņas

Elevance Health 1Q Adj EPS $11.97 >ELV

2025. g. 22. apr. 10:00 UTC

Peļņas

Elevance Health 1Q Medical Enrollment Members 45.8M >ELV

2025. g. 22. apr. 10:00 UTC

Peļņas

Elevance Health 1Q EPS $9.61 >ELV

2025. g. 17. apr. 20:34 UTC

Peļņas

UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com

2025. g. 17. apr. 18:24 UTC

Peļņas

UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com

2025. g. 3. febr. 17:56 UTC

Top Ziņas

Trump's Medicaid Comments on Friday Provide Relief for Insurers -- WSJ

2025. g. 23. janv. 14:54 UTC

Peļņas

Elevance Earnings: Stock Rises After Results and Guidance Match Expectations -- WSJ

2025. g. 23. janv. 14:54 UTC

Peļņas

Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. -- Barrons.com

2025. g. 23. janv. 12:35 UTC

Peļņas

Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive. -- Barrons.com

2025. g. 23. janv. 11:02 UTC

Peļņas

Elevance Health Raises Dividend to $1.71 >ELV

2025. g. 23. janv. 11:02 UTC

Peļņas

Elevance Health Sees 2025 Adj EPS $34.15-Adj EPS $34.85 >ELV

2025. g. 23. janv. 11:01 UTC

Peļņas

Elevance Health Sees 2025 EPS $30.40-EPS $31.10 >ELV

2025. g. 23. janv. 11:00 UTC

Peļņas

Elevance Health 4Q Benefit Expense Ratio 92.4% >ELV

2025. g. 23. janv. 11:00 UTC

Peļņas

Elevance Health 4Q Net $418M >ELV

2025. g. 23. janv. 11:00 UTC

Peļņas

Elevance Health 4Q EPS $1.81 >ELV

2025. g. 23. janv. 11:00 UTC

Peļņas

Elevance Health 4Q Rev $45.44B >ELV

2025. g. 23. janv. 11:00 UTC

Peļņas

Elevance Health 4Q Adj EPS $3.84 >ELV

Salīdzinājums

Cenas izmaiņa

Elevance Health Inc Prognoze

Cenas mērķis

By TipRanks

32.96% augšup

Prognoze 12 mēnešiem

Vidējais 497.67 USD  32.96%

Augstākais 585 USD

Zemākais 428 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Elevance Health Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

15 ratings

12

Pirkt

3

Turēt

0

Pārdot

Noskaņojums

By Acuity

150 / 382 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Elevance Health Inc

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.